Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Treasury Shares (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Treasury Shares data on record, last reported at $119102.0 in Q3 2025.

  • For Q3 2025, Treasury Shares fell 33.54% year-over-year to $119102.0; the TTM value through Sep 2025 reached $119102.0, down 33.54%, while the annual FY2024 figure was $164174.0, 3.96% down from the prior year.
  • Treasury Shares reached $119102.0 in Q3 2025 per CYCN's latest filing, down from $134126.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $809417.0 in Q1 2023 and bottomed at $34362.0 in Q2 2023.
  • Average Treasury Shares over 5 years is $159839.0, with a median of $134126.0 recorded in 2025.
  • Peak YoY movement for Treasury Shares: tumbled 74.6% in 2022, then surged 465.22% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $92804.0 in 2021, then plummeted by 56.07% to $40772.0 in 2022, then skyrocketed by 319.25% to $170937.0 in 2023, then fell by 3.96% to $164174.0 in 2024, then decreased by 27.45% to $119102.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $119102.0 in Q3 2025, $134126.0 in Q2 2025, and $149150.0 in Q1 2025.